WS
DGX icon

Wedbush Securities’s Quest Diagnostics DGX Stock Holding History

Wedbush Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Buy
+1,436
New +$279K 0.01% 940
2025
Q4 		– Sell
-1,157
Closed -$221K – 1222
2025
Q3 		$221K Sell
1,157
-16
-1% -$2.84K 0.01% 1018
2025
Q2 		$211K Sell
1,173
-165
-12% -$28.7K 0.01% 1029
2025
Q1 		$226K Sell
1,338
-14
-1% -$2.3K 0.01% 953
2024
Q4 		$204K Buy
+1,352
New +$210K 0.01% 1024
2024
Q3 		– Sell
-2,404
Closed -$329K – 1142
2024
Q2 		$329K Sell
2,404
-190
-7% -$26K 0.01% 815
2024
Q1 		$345K Buy
2,594
+158
+6% +$20.5K 0.01% 805
2023
Q4 		$336K Buy
+2,436
New +$320K 0.01% 719
2023
Q3 		– Sell
-2,078
Closed -$292K – 1067
2023
Q2 		$292K Sell
2,078
-100
-5% -$13.8K 0.01% 771
2023
Q1 		$308K Sell
2,178
-538
-20% -$77K 0.02% 744
2022
Q4 		$425K Buy
2,716
+100
+4% +$14.4K 0.02% 580
2022
Q3 		$321K Sell
2,616
-571
-18% -$75.2K 0.02% 685
2022
Q2 		$424K Sell
3,187
-24
-0.7% -$3.27K 0.02% 592
2022
Q1 		$439K Sell
3,211
-173
-5% -$24.1K 0.02% 643
2021
Q4 		$585K Buy
3,384
+13
+0.4% +$1.98K 0.03% 559
2021
Q3 		$490K Buy
3,371
+41
+1% +$6K 0.02% 627
2021
Q2 		$439K Sell
3,330
-61
-2% -$7.99K 0.02% 679
2021
Q1 		$435K Buy
3,391
+1,415
+72% +$174K 0.02% 636
2020
Q4 		$235K Sell
1,976
-425
-18% -$51.8K 0.02% 738
2020
Q3 		$275K Buy
2,401
+175
+8% +$20.7K 0.03% 647
2020
Q2 		$254K Sell
2,226
-706
-24% -$74.9K 0.02% 668
2020
Q1 		$235K Sell
2,932
-968
-25% -$100K 0.03% 615
2019
Q4 		$417K Buy
3,900
+2
+0.1% +$209 0.04% 534
2019
Q3 		$417K Sell
3,898
-833
-18% -$85.5K 0.04% 512
2019
Q2 		$482K Buy
4,731
+199
+4% +$19.1K 0.05% 448
2019
Q1 		$408K Buy
4,532
+1,272
+39% +$110K 0.04% 484
2018
Q4 		$271K Buy
3,260
+649
+25% +$60.8K 0.03% 570
2018
Q3 		$282K Hold
2,611
– – 0.03% 607
2018
Q2 		$287K Sell
2,611
-283
-10% -$29.5K 0.04% 572
2018
Q1 		$290K Sell
2,894
-855
-23% -$87.6K 0.04% 540
2017
Q4 		$369K Buy
3,749
+25
+0.7% +$2.37K 0.05% 477
2017
Q3 		$349K Sell
3,724
-957
-20% -$102K 0.05% 497
2017
Q2 		$520K Buy
4,681
+754
+19% +$79.7K 0.07% 378
2017
Q1 		$386K Sell
3,927
-130
-3% -$12.4K 0.05% 434
2016
Q4 		$373K Buy
4,057
+582
+17% +$50.2K 0.05% 419
2016
Q3 		$294K Sell
3,475
-110
-3% -$9.24K 0.04% 524
2016
Q2 		$292K Buy
3,585
+202
+6% +$15.4K 0.05% 471
2016
Q1 		$242K Sell
3,383
-77
-2% -$5.16K 0.04% 517
2015
Q4 		$246K Buy
+3,460
New +$233K 0.04% 480
2015
Q3 		– Sell
-3,140
Closed -$228K – 735
2015
Q2 		$228K Sell
3,140
-254
-7% -$18.8K 0.04% 528
2015
Q1 		$261K Buy
+3,394
New +$243K 0.04% 474
2014
Q3 		– Sell
-5,113
Closed -$300K – 700
2014
Q2 		$300K Sell
5,113
-1,357
-21% -$79.5K 0.05% 388
2014
Q1 		$375K Buy
+6,470
New +$347K 0.07% 305

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Wedbush Securities's DGX Position: Q1 2026 in Review

Wedbush Securities opened a new position in Quest Diagnostics (DGX) in Q1 2026: 1,436 shares worth $281K. The stake represents 0.01% of the portfolio and ranks #940 among its holdings. This is a return to the name: Wedbush Securities previously reported a position in DGX as recently as Q3 2025.

Wedbush Securities first reported a position in DGX in Q1 2014 and has held it in 43 quarters since. The position peaked at $585K in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Wedbush Securities held 1,436 shares of Quest Diagnostics worth $281K as of Q1 2026.
  • Quest Diagnostics was a new Wedbush Securities position in Q1 2026.
  • Quest Diagnostics made up 0.01% of Wedbush Securities's portfolio in Q1 2026, its #940 holding.
  • Wedbush Securities first reported a position in Quest Diagnostics in Q1 2014 and has held it in 43 quarters since.
  • Wedbush Securities's Quest Diagnostics position peaked at $585K in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.